Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I)

Clinical trial NCT03093974 · COMPLETED

Trial details

NCT number: NCT03093974
Sponsor: Zambon SpA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non Cystic Fibrosis Bronchiectasis

Start date: 2017-06-06
Primary completion: 2021-04-09
Enrollment: 377

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.